Advertisement
High-deductible health plans are becoming more common among U.S. adults with employer-sponsored health insurance coverage

CDC: High-Deductible Health Plan Use Rising Among Employers

0
These employees more likely to face financial barriers to care, researchers find
There is little agreement between the American Society of Clinical Oncology Value Framework and European Society for Medical Oncology Magnitude of Clinical Benefit Scale

ASCO: Agreement Lacking With ESMO on Most Effective Drugs

0
Negative correlation identified for ASCO benefit score with monthly incremental drug costs
From 2013 to 2015 there was a decrease in additional surgery after initial lumpectomy

ASCO: Recent Drop in Additional Surgery Post Lumpectomy

0
Decrease was concomitant with 2014 consensus statement endorsing a margin of no ink on tumor
Two new medications that target specific genetic mutations may improve survival for patients with specific types of advanced non-small-cell lung cancer

ASCO: Novel Meds Show Promise in Advanced NSCLC

0
Results presented from two phase III trials
A new type of immunotherapy appears to provide long-lasting protection against multiple myeloma

ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma

0
Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein
Over the past 60 years

ASCO: SWOG Trials Have Had Considerable Impact on Cancer

0
Estimated 3.34 million life-years gained through 2015 from 23 positive SWOG treatment trials
Free meals

ASCO: Industry Perks Influence Physicians’ Choice of Cancer Rx

0
Even relatively small payments appear to make a difference, researchers say
Just one dose of radiation works as well as a full week of treatment for metastatic spinal canal compression

ASCO: Single Radiation Tx Enough for Spinal Pain in Cancer Mets

0
Researchers suggest it works as well as a full week of treatments
Olaparib (Lynparza) monotherapy can provide a significant benefit over standard therapy in women with human epidermal growth factor receptor type 2-negative metastatic breast cancer and a germline BRCA mutation

ASCO: Olaparib Efficacious in BRCA-Related Breast Cancer

0
May offer a new treatment for women with advanced BRCA-related disease, researchers say
A patient-reported outcome intervention for symptom monitoring is associated with improved overall survival for patients treated with chemotherapy for metastatic solid tumors

ASCO: Survival Up With Patient-Reported Outcomes During CA Tx

0
Improved survival with patient-reported outcomes for symptom monitoring in metastatic cancer